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Abstract 
The molecular mechanism between atherosclerosis formation and periodontal 
pathogens is not clear although positive correlation between periodontal infections 
and cardiovascular diseases has been reported. Objective: To determine if 
atherosclerosis related genes were affected in foam cells during and after its formation 
by P. gingivalis lipopolysaccharide (LPS) stimulation.  Methods: Macrophages from 
human THP-1 monocytes were treated with oxidized low density lipoprotein (oxLDL) 
to induce the formation of foam cells. P. gingivalis LPS was added to cultures of 
either oxLDL-induced macrophages or foam cells. The expression of atherosclerosis 
related genes was assayed by quantitative real time PCR and the protein production of 
granulocyte-macrophage colony-stimulating factor（GM-CSF）, monocyte chemotactic 
protein-1 (MCP-1), IL-1β, IL-10 and IL-12 was determined by ELISA. Nuclear 
translocation of NF-κB P65 was detected by immunocytochemistry and western blot 
was used to evaluate IKB-α degradation to confirm the NF-κB pathway activation.  
Results: P. gingivalis LPS stimulated atherosclerosis related gene expression in foam 
cells and increased oxLDL induced expression of chemokines, adhesion molecules, 
growth factors, apoptotic genes, and nuclear receptors in macrophages. Transcription 
of the pro-inflammatory cytokines IL-1β and IL-12 was elevated in response to LPS 
in both macrophages and foam cells, whereas the anti-inflammatory cytokine IL-10 
was not affected. Increased NF-κB pathway activation was also observed in LPS and 
oxLDL co-stimulated macrophages. Conclusion: P. gingivalis LPS appears to be an 
important factor in the development of atherosclerosis by stimulation of 
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atherosclerosis related gene expression in both macrophages and foam cells via 
activation of the NF-κB pathway. 
 4 
 
Background 
Periodontal disease is a condition that affects the supporting tissues surrounding 
the teeth, and which, in severe cases, can result in tooth loss. There is a growing body 
of epidemiological evidence to suggest that pathogenic periodontal bacterial species 
may play a role in the development of cardiovascular diseases (1, 2). For example, 
ApoE-/- atherosclerosis-prone mice infected, by blood or oral inoculation, with P. 
gingivalis, a principal pathogen in periodontitis, showed signs of accelerated 
atherosclerosis and P. gingivalis DNA was found in the aortic tissues of infected mice 
(3, 4). Furthermore, blood transfusion of P. gingivalis LPS accelerates the progression 
of atherosclerosis in ApoE-/- mice (5). The molecular mechanisms between LPS from 
P. gingivalis and atherosclerosis are not clear, although evidence points to a 
correlation between atherosclerosis and periodontal infection. 
Atherosclerosis is a chronic inflammatory disease characterized by the early and 
persistent presence of macrophages in the arterial wall (6). Scavenger receptors 
mediate macrophage uptake of oxLDL particles, which leads to intracellular 
cholesterol accumulation and the formation of foam cells (7).  Upon entering the 
blood circulatory system, live P. gingivalis, its outer membrane vesicles, or its LPS in 
the presence of LDL, can also promote foam cell formation (8, 9), possibly by LPS 
interacting with cell constituent structures, such as Toll-like receptors (TLR)-2/-4 and 
the glycosylphosphatidylinositol (GPI) linked protein CD14, on macrophages located 
at lipid-laden sites. This leads to an inflammatory response (10), which in turn leads 
to the modified lipid metabolism in the activated macrophages (8). 
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To our knowledge there are no reports addressing the global effects of P. 
gingivalis LPS on atherosclerosis related gene expression in macrophages/foam cells 
in the presence of oxLDL. In this study we therefore tested the hypothesis that P. 
gingivalis LPS could alter the global expression profile of atherosclerosis related 
genes in macrophages and foam cells. We investigated the gene profile of 
macrophages incubated in the presence of oxLDL to tease out the role of P. gingivalis 
LPS on macrophages during and after foam cells formation. Our results indicate that 
LPS from P. gingivalis may stimulate atherosclerosis related gene expression in 
macrophages and foam cells in the presence of oxLDL through the enhanced 
activation of NF-κB pathway. 
 
MATERIALS AND METHODS 
Lipoprotein Preparation 
LDL (d=1.019 to 1.063 g/mL) was isolated by sequential ultracentrifugation of 
sera from five healthy donors who had fasted for 12 to 14 hr. Informed consent was 
obtained from the subjects and the study protocol was approved by the Institutional 
Review Board of Fujian Medical University China, the LDL fraction was oxidized by 
a 12 hr treatment with CuSO4 as described previously (11). The extent of lipid 
oxidation was assessed with thiobarbituric acid-reactive substance (TBARs) assay to 
detect malondialdehyde (MDA)-like compounds. The amount of TBARS in our 
sample was 40±5 nmol MDA equivalent/mg protein. Endotoxin content of all LDL 
preparations was measured with the Limulus amebocyte lysate kit and was always 
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<50 pg/100 mg LDL protein. The LDL and oxLDL were stored under N2 at 4 °C for 
up to 2 weeks. 
 
Cell culture and stimulation 
Human THP-1 monocytes (American Type Tissue Culture Collection, Camden, NJ, 
USA) were placed into 24- or 6-well plates with glass slipcovers, then grown in 
suspension at 37°C and 5% CO2 in bicarbonate-buffered RPMI 1640 medium 
supplemented with 10% fetal bovine serum (v/v), 100 U/mL penicillin, and 100 
μg/mL streptomycin (GIBCO-BRL Life Technologies, Guangzhou, China). The 
THP-1 monocytes were induced to differentiate into macrophages with 160 nmol/L 
phorbol 12-myristate,13-acetate (PMA) (Sigma, St. Louis, MO,USA) for 36 hr, then 
cultivated in serum-free medium for 24 hr prior to exposure to further stimuli. The 
effects of LPS on foam cell formation was studied by culturing macrophages under 
the following condition: (1) RPMI 1640 medium; (2) RPMI 1640 medium + 50 
μg/mL oxLDL; (3) RPMI 1640 medium + 50 μg/mL oxLDL +1 µg/mL LPS. To study 
the effects of LPS after foam cell formation, macrophages were first incubated with 
50 μg/mL oxLDL for 48 hr for foam cells formation, and then cultured in the 
following condition: (4) RPMI 1640 medium + 50 μg/mL oxLDL; (5) RPMI 1640 
medium + 50 μg/mL oxLDL +1 µg/mL LPS. The LPS was sourced from the P. 
gingivalis strain ATCC 33277 (InvivoGen, San Diego, CA, USA). The potency of the 
P.gingivalis LPS in this study is more than 1.25×104 EU/mg by Limulus amebocyte 
lysate assay, and the purity of this LPS is more than 95 percent. 
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Oil Red O staining and Lipid analysis  
Foam cells formation of macrophages due to 36hr or 48 hr incubation with 50 
μg/mL oxLDL was determined by Oil Red O staining. The total and free cholesterol 
in macrophages was assayed with a biochemical kit (Merck, Darmstadt, Germany) 
described by Gamble et al (12). The ratio of cholesterol esters to total cholesterol was 
further assessed to confirm foam cells formation. 
 
RT² Profiler™ PCR array  
The expression of atherosclerosis genes, following oxLDL and LPS stimulation, 
was assayed using an atherosclerosis-specific real-time PCR array (OHS-037, 
SuperArray SABiosciences, Frederick, MD, USA) according to the manufacture’s 
instructions. Total RNA was isolated from 3 individual cell cultures in the same 
treatment using 1ml of Trizol reagent as described by the manufacturer (Invitrogen 
Life Technologies, Carlsbad, CA, USA). All RNA samples were DNase treated and 
purified using the RNeasy kit (QIAGEN Inc, Valencia, CA, USA). The quality of total 
RNA was assessed by visualization of intact 18S and 28S ribosomal bands on a 1.2% 
formaldehyde agarose gel. One microgram of total RNA was used to synthesize 
template cDNA using the SuperArray RT² First Strand Synthesis Kit following the 
manufacturer’s protocol. The template cDNA was mixed with 2x RT² qPCR Master 
Mix and 25 μL of the cocktail aliquoted into each well on the PCR array plate, which 
contained pre-dispensed gene specific primer sets. Each plate consisted of a panel of 
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96 primer sets of 84 atherosclerosis related genes, plus five housekeeping genes and 
three RNA and PCR quality controls. Reactions were carried out using a 7300 Real 
Time PCR System (Applied Biosystems, Foster City, CA, USA). PCR amplification 
followed a two-step cycling program: 10 min activation step at 95˚C, 40 cycles of 
95˚C for 15 sec and 60˚C for 1 min. Details of the RT² PCR arrays are available at 
http://www.superarray.com. Genes were considered as differentially expressed if there 
was a 2.0-fold difference with statistical significance in their expression values. 
Real-time PCR 
The RT² Profiler™ PCR kit did not include the important inflammatory cytokines 
IL-1β, Il-10, and IL-12, so the gene expression of these were assayed separately by 
real-time PCR. 
Briefly, total RNA was extracted from cells using Trizol reagent and 1g was used 
to synthesize template cDNA using a High Capacity RNA-to-cDNA Kit (Applied 
Biosystems, Warrington, Cheshire, UK).  Gene specific primers were designed by 
Taqman Primer Express Software V5.0 and are shown in Table1. Real-time PCR was 
performed in a 25 μL reaction volume containing 12.5 μL SYBR green Master Mix 
(Applied Biosystems), 2.5 μL (10 μM) of each forward and reverse primer for each 
gene of interest for a final concentration of 20 pmol, 2.5 μL of cDNA template and 5 
L of RNase free water. The reactions were performed in triplicates and the house 
keeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a 
control. The reaction was performed on an ABI Prism 7000 Sequence Detection 
System (Applied Biosystems) and the PCR amplification followed 1 cycle of 30 min 
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at 48˚C, 1 cycle of 10 min at 95˚C, 40 cycles of 15s at 95˚C and 60˚C for 1 min. 
Melting curve analysis was performed to validate that the specific amplicons were 
free from genomic DNA contamination. Relative expression levels for each gene were 
normalized by the Ct value of the house keeping gene and calculated using the ΔCt 
method.  
 
ELISA 
Protein expression levels of GM-CSF, MCP-1, IL-1β, IL-10 and IL-12 were 
assayed with an ELISA Kit (GM-CSF, IL-10 and IL-12: R&D System, Minneapolis 
MN,USA; MCP-1 and IL-1β: Jingmei Biotech, Beijing, China) according to the 
manufacturer’s instructions, from supernatants of conditioned medium collected after 
cells had been treated with LPS and oxLDL as described above.  
 
Western Blot 
 Altered expression of nuclear receptor genes detected in the PCR array was 
further probed by looking at NF-κB pathway activation by western blot analysis of 
IκB-α protein expression. A total of 3×106 macrophage cells in 5 mL culture media 
were cultivated in 60 mm discs. The cells were treated with oxLDL and/or LPS for 2 
hr before being harvested in a lysis buffer. Fifty micrograms of total protein from each 
sample was denatured and then separated an 8% SDS polyacrylamide gel and then 
transferred to nitrocellulose membrane. The membrane was then blocked with 5% 
(w/v) bovine serum albumin (BSA) for 1h at room temperature and incubated with 
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rabbit anti-human IKB-α polyclonal antibody (1:1000 dilution; Upstate Biotech, Lake 
Placid, NY, USA), then with a secondary antibody of goat anti-rabbit horseradish 
peroxidase-linked IgG at 2 μg/mL (Kangchen, Shanghai, China). Actin was used  as 
a loading control using a rabbit anti-actin antibody at1μg/mL (Kangchen, Shanghai, 
China). The bands were visualized using enhanced chemiluminescence (ECL). Finally, 
the signals strength was estimated using the NIH Image J system 
(http://rsbweb.nih.gov/ij/index.html). 
 
Immunocytochemistry  
 Activation of the NF-κB pathway was confirmed by probing for the nuclear 
translocation of NF-κB p65 subunits using immunocytochemistry. Macrophages, 
grown on cover slips, were collected at 0 min, 30 min, and 1, 2, and 4 hr after the 
addition of oxLDL and LPS. The cellular components were treated according to the 
manufacturer’s protocol and probed with anti-RelA P65 (1:100 dilution; Santa Cruz 
Biotech, Santa Cruz, CA, USA), then incubated with secondary antibodies (Dako, 
Glostrup, Denmark). The antibody binding was visualized with diaminobenzidine  
(Dako) in 0.06% hydrogen peroxide (H2O2) and the number of nuclear-positive cells, 
in a total of four hundred cells, were counted to determine the rate of positive nuclear 
translocation. 
 
Statistical Analysis 
The data shown in all the figures are expressed as means ± standard deviation (SD) 
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of at least three repeated experiments. Comparisons of multiple groups were 
performed by ANOVA and a Student-Newman-Keuls post-ANOVA multiple 
comparison test when the ANOVA was significant. The two-tailed Mann–Whitney t 
test was applied when two mean values were compared. P<0.05 was considered 
statistically significant. 
 
 
RESULTS 
Analysis of foam cell formation 
 The rate of cholesterol ester to total cholesterol in the macrophages all exceeded 
50 per cent following incubation with 30, 50, or 80 μg/mL oxLDL for 48 hr (Fig 1A). 
An obvious intracellular lipid droplet formation was observable when incubated with 
50 μg/mL oxLDL for 48h (Fig 1B), which further confirmed foam cell formation.  
 
P. gingivalis LPS enhanced atherosclerotic gene expression in oxLDL induced 
macrophages 
The expression of about 40 of the 87 atherosclerotic genes were altered following  
ox-LDL and LPS treatments, and many of the same genes differentially regulated by 
oxLDL were also influenced by P. gingivalis LPS. Interestingly, most of the genes 
up-regulated by oxLDL were further up-regulated by LPS, and similarly, genes that 
were down-regulated by oxLDL were further down-regulated by LPS; P. gingivalis 
LPS therefore enhanced the gene alteration caused by oxLDL in macrophages (Table 
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2). 
Cell adhesion molecules, chemokines and growth factors expression was also 
up-regulated by oxLDL alone or with LPS. MCP-1(CCL2), RANTES(CCL5), 
vascular cell adhesion molecule-1(VCAM-1), and granulocyte/macrophage-colony 
stimulating factor (GM-CSF) expression was increased by 1.22-, 3.88- , 1.15- and 
18.92- fold respectively in the oxLDL treatment  groups, and increased to 2.87-, 
8.55-, 30.48- and 225.91- fold respectively in the oxLDL plus LPS group. 
Platelet-derived growth factor-α (PDGF-α) expression was down-regulated by oxLDL 
and further down-regulated by the addition of LPS (Table 2).  
 
The apoptotic gene BCL2-related protein A1 (BCL2A1) was up-regulated by 
oxLDL stimulation, and further up-regulated by LPS. Genes involved in lipid 
transport and metabolism were also affected: for example, ATP-binding cassette, 
sub-family A-1 (ABCA1) and Apolipoprotein A-1 (ApoA-1) expression was increased 
by 3.50- and 2.17- fold in the oxLDL groups and increased to 3.62- and 1.06- fold in 
LPS plus oxLDL groups, whereas the low density lipoprotein receptor (LDLR) was 
attenuated by 1.96- in oxLDL and 2.23- fold in oxLDL plus LPS groups. The 
expression of the transcription factor peroxisome proliferator-activated receptor-γ 
(PPAR-γ) was lower in both the oxLDL and oxLDL plus LPS groups, 2.56- and 
5.26-fold respectively (Table 2).  
 
Effects of P. gingivalis LPS on oxLDL induced foam cells 
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 Incubating macrophages with oxLDL 48 hr resulted in even greater changes in 
gene expression. The total number of genes either up-or down-regulated in oxLDL 
treated macrophages was 28, and 33 in oxLDL plus LPS treated macrophages. The 
corresponding numbers in foam cells was 42 and 45 respectively, suggesting a 
different biological response to LPS between macrophages and foam cells (Table 3). 
The expression of atherosclerosis related gene expression in foam cells in response 
to P. gingivalis LPS stimulation was quite different from that of macrophages: a total 
of 11 genes were up-regulated and only IL-5 was down-regulated, 2.5- fold, compared 
to oxLDL stimulation alone (Table 4). The most striking up-regulated gene was 
granulocyte-macrophage colony stimulating factor (GM-CSF) which was 
up-regulated by 151.69-fold in oxLDL alone and a massive 323.35- fold in oxLDL 
plus LPS compared to un-stimulated macrophages. Selectin-E was up-regulated 
24.87-fold in oxLDL and 58.53- fold in LPS plus oxLDL respectively (Table 4). 
 
Effects of P. gingivalis LPS on some inflammatory cytokine gene expression of 
IL-1β, IL-10 and IL-12 
The atherosclerosis-specific real-time PCR array kit (RT² Profiler™ PCR) does 
not contain the important inflammatory cytokines IL-1β, Il-10, and IL-12. The gene 
expression of these markers was studied separately by quantitative real-time PCR and 
showed in Figure 2. P. gingivalis LPS treatment resulted in significant up-regulation 
of IL-1β in both macrophages and foam cells with a more than two fold increase in 
macrophages but only a 0.4 fold increase in foam cells compared with the cells 
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cultured without LPS (Fig 2A). The expression of IL-12 increased a robust 26.84 fold 
in macrophages and 16.34 fold in foam cells (Fig 2B) with the stimulation of LPS, 
whereas IL-10 was not significantly influenced by LPS stimulation compared with 
oxLDL preinculabted macrophages and foam cells (Fig 2C).  
Validation of selected mRNA expression induced by P. gingivalis LPS by ELISA assay  
Protein levels of GM-CSF, MCP-1, IL-1β, IL-10 and IL-12 in the supernatants at 
2 hr, 6 hr and 12 hr after incubation were determined to confirm the mRNA data in 
both the real-time PCR and PCR array studies. LPS from P. gingivalis enhanced 
GM-CSF production during foam cells formation, and enhanced secretion of MCP-1 
in both oxLDL induced macrophages and foam cells at 6 and 12 hr (Fig 3A and 3B). 
Production of pro-inflammatory cytokine IL-1β and IL-12 was significantly higher by 
P. gingivalis LPS plus oxLDL stimulation compared to LDL stimulation alone during 
and after foam cells formation (Fig 3C and 3E). However, the prominent 
anti-inflammatory cytokine, IL-10, was not significantly influenced by LPS 
stimulation compared with oxLDL alone incubated macrophages and foam cells (Fig 
3D). These data suggested P. gingivalis LPS had a predominantly additive effect on 
pro-inflammatory cytokines in oxLDL induced macrophages and foam cells. 
 
NF-κB pathway activation 
 NF-κB P65 translocation was seen as early as 15 min in the experimental groups 
(Fig 4A), but was not detectable in the controls (result not shown). NF-κB P65 
translocation was significantly greater in the oxLDL plus LPS group compared to the 
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oxLDL only group (Fig 4A and 4B). Cytoplasmic IκB-α levels at 2 hr decreased 
proportionally with the increased NF-κB P65 translocation, levels of IκB-α in 
cytoplasm decreased in 2 h (Fig 4C and 4D) and a time dependent decrease was seen 
in the  oxLDL plus LPS group (Fig 4E and 4F), which confirmed NF-κB activation. 
The influence of P. gingivalis LPS on NF-κB translocation rate and IκB-α expression 
also appeared to be concentration-dependent. 
 
Discussion  
Porphyromonas gingivalis is an important etiological agent of chronic adult 
periodontitis and may be associated with systemic diseases including atherosclerosis. 
LPS is a major structural component of the outer cell membrane of gram-negative 
bacteria such P. gingivalis (13). LPS from P. gingivalis induces an inflammatory 
response mainly through activation of TLR2, and affects a less potent response from 
the innate immune system compared to LPS derived from other gram-negative 
bacteria such as Escherichia coli (14). ApoE-deficient mice developed significantly 
increased artherosclerotic lesions in response to blood infused P. gingivalis LPS (5). 
In the present study we were able to demonstrate that P. gingivalis LPS play an 
important role by modulating atherosclerosis related gene expression in macrophage 
and foam cells. 
P. gingivalis LPS has been shown to have greater ability to induce the 
production of IL-8, MCP-1, RANTES, VCAM-1, and VEGF than does live P. 
gingivalis,  suggesting that LPS from P. gingivalis may exert a more profound in 
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atherogenic  role than does live P. gingivalis (15). In this study we demonstrate that 
P. gingivalis LPS up-regulated, in macrophages, the expression of adhesion molecules 
such as CD44, VCAM-1, Selectin-E and ICAM-1; chemokines such as 
MCP-1(CCL2) and RANTEs (CCL5); and growth factors such as GM-MSF. 
Moreover, P. gingivalis LPS also increased the expression of Selectin-E, GM-MSF 
and connective tissue growth factor (CTGF) in oxLDL induced foam cells. Increased 
expression of these molecules may enhance the aggregation of additional monocytes, 
smooth muscle cells and T-lymphocytes into the lipid-laden atherosclerotic lesions, 
and thereby participating in the progress of atherosclerosis. 
It is now well-established that atherosclerosis, besides being a lipid disorder, is 
also symptomatic of a state of chronic inflammation (6).  Macrophages, when 
activated,  produce both pro- and anti-inflammatory cytokines, which  affect 
surrounding cells as well as having an autocrine effect (14). Our PCR results suggest 
that, in oxLDL induced macrophages and foam cells, P. gingivalis LPS enhances the 
inflammatory process by up-regulating transcription of the pro-inflammatory factors 
IL- 1β and IL-12.  The inflammatory response is a tightly regulated system, the 
activation of which is under the control of autocrine feedback mechanisms. IL-10 is a 
major anti-inflammatory cytokine and our results showed that IL-10 was more 
strongly up-regulated in foam cells compared to macrophages, suggesting that when 
exposed to a prolonged inflammatory challenge the host immune cells may try to 
suppress the inflammatory process by increasing IL-10 expression. These results 
contrast to those reported by Groeneweg et al. (16) who found lower IL-10 expression 
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in foam cells than in macrophages.  Interestingly, we did not find that IL-10 
expression of in foam cells was affected by P. gingivalis LPS and together these data 
suggest that P. gingivalis LPS exacerbates the inflammatory response in host cells 
through a process of increased pro-inflammatory cytokine expression rather than 
inhibiting the anti-inflammatory pathway.  
Apoptosis may be another potential mechanism through which oxLDL influences 
the inflammatory response. This is all the more possible given that the expression of 
pro-apoptotic genes, such as B-cell CLL/lymphoma 2(BCL-2), BCL2-related protein 
A1 (BCL2A1), Baculoviral IAP repeat containing 3 (BIRC-3), and anti-apoptotic 
gene, such as CASP8 and FADD-like apoptosis regulator (CFLAR) were affected by 
oxLDL stimulation.  The resulting enhanced apoptotic gene responses an indication 
that the balance between pro-apoptotic and anti-apoptotic gene expression was 
disturbed in macrophages and foam cells; a TUNEL assay could be used to detect if P. 
gingivalis LPS leads to increased DNA fragmentation, confirmation of activation of 
the apoptotic pathway. 
 The PCR array data suggests that P. gingivalis LPS have an additive effect on 
oxLDL regulated genes, further activating the nuclear receptor subfamily 1, group H, 
member 3 (NR1H3), and inhibiting the peroxisome proliferator-activated receptor γ 
(PPARγ). This supports the notion that LPS functions as a negative regulator of 
PPARγ in macrophages, and that this may, in fact, accelerate foam cells formation 
(17). Changes such as these, to nuclear receptors and transcriptional factors, lead to 
extensive changes to downstream genes transcription. ATP-binding cassette 
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transporter A1 (ABCA1), an integral membrane protein that transports intracellular 
cholesterol out of the membrane (18) , which is influenced by PPARγ level, was 
up-regulated by oxLDL or oxLDL plus LPS stimulation. It may be that such effects 
are part of a feedback mechanism used by the host cells to reduce the increased 
intracellular lipid extent. Whereas we saw an increased ABCA1 transcription, Ma and 
colleagues report that ABCA1 expression is decreased in foam cells isolated from 
smooth muscle tissues (19). It appeared that, as a response to increased intracellular 
lipid extent, macrophages transcribed less of LDL receptors and macrophages 
scavenger receptor-1(MSR-1) genes; this would have the effect of decreasing inward 
lipid transport, on top of increased outward lipid transport.  
The PCR array data showed that there was enhanced NF-κB pathway activation in 
response to P. gingivalis LPS and oxLDL stimulation. The transcriptional factor 
NF-κB is an important player in gene regulation during inflammatory, immune 
reactions and cell apoptosis (20). Activated NF-κB has been identified in 
atherosclerotic lesions, e.g. in monocytes/macrophages or endothelial cells (21). 
NF-κB exists as a dimer which is trapped in the cytosol in an inactive state by 
inhibitory proteins, including IκB-α. The activation of NF-κB is facilitated by the IκB 
-kinase (IKK) complex, consisting of IKK-α, -β, and -γ. Activation of IKK leads to 
IκB phosphorylation which is subsequently degraded by the proteasome, followed by 
nuclear translocation of NF-κB (22). Increased NF-κB nuclear translocation rate with 
simultaneously decreased IκB-α in cytosol has been observed in oxLDL plus LPS 
stimulation group,  thus our results indicated that there is a possible role of NF-κB in 
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mediating the pro-atherosclerotic gene and cytokine expression, thus leading to foam 
cell formation, a crucial event in atherogenesis. 
 Alterations in NF-κB pathway gave us a clue to understand the possible 
mechanism of P. gingivalis LPS on oxLDL role in foam cells.  P. gingivalis LPS and 
oxLDL may together interact with cell constituent structures, such as Toll-like 
receptors (TLR)-2/-4 and the glycosylphosphatidylinositol (GPI) linked protein 
CD14, on macrophages, therefore activate the same pathway, such as the NF-κB 
pathway investigated in this study. This synergistic effect of oxLDL and LPS from P. 
gingivalis then generated pleiotropic roles, which in turn leaded to altered cell 
function and morphology in foam cells.  
 Here we report some of the cellular responses of oxLDL induced macrophages 
and foam cells to P. gingivalis LPS. The particular focus of this study was the effects 
of LPS on oxLDL induced macrophages during and after foam cell formation.  For 
this reason, for the most part we did not include a P. gingivalis LPS alone treatment 
group, however, we did include an LPS control group with the ELISAs for the 
purpose of exploring the inflammatory effect of LPS and the time-dependent 
response. Groeneweg and colleagues reported that prior exposure to oxLDL enhanced 
E. coli LPS-induced gene expression in murine macrophages (16). Our experimental 
model revealed a different gene expression profile by P. gingivalis LPS in oxLDL 
induced macrophages and foam cells. 
It is known from previous publications that LPS from P.gingivalis and E. coli 
activates different Toll-like Receptors and intracellular signaling pathways. P. 
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gingivalis LPS is mainly through TLR2–JNK pathway to induce cytokine production 
in THP-1 macrophages; whereas E. coli LPS was mainly via TLR4–p38MAPK 
pathway to produce the cytokine induction (23). Thus P.gingivalis LPS may generate 
an atherosclerotic gene profile that is different from E. coli LPS, however, future 
work is needed to discriminate whether the differential expression of atherosclerotic 
gene expression is a general phenomenon under LPS stimulation or species dependent. 
One more limitation of this study is that we only used a commercially available LPS 
from P. gingivalis (ATCC 33277).  As P. gingivalis produces different isoforms of 
LPS in different conditions (24), it will be interesting to know whether other isoforms 
of LPS from P. gingivalis will have similar effect on the alteration of atherosclerotic 
genes in macrophages and foam cells. One more limitation of the current study is that 
we did not include P. gingivalis live strain in the study. As common gentle daily 
activities such as tooth brushing are potential source for bacteremia, it will be very 
interesting to compare the effect of P. gingivalis live microbes with LPS from P. 
gingivalis or other periodontal pathogens on atherosclerosis. 
 Based on the atherosclerosis related genes examined in this study, albeit a limited 
number, we propose these tentative conclusions: (i) P. gingivalis LPS appears to 
enhance the expression of genes related to cell chemotactic activity, adhesion and 
growth, as well as genes related to apoptosis in both macrophages and foam cells; (ii)  
P. gingivalis LPS up-regulates nuclear receptor expression and enhances the 
activation of the NF-κB pathway, which leads to pleiotropic changes in gene 
expression in response to LPS stimulation in these cells.  
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A better understanding of the cell molecular mechanisms involved in periodontal 
pathogen infection and atherogenesis should give us a clearer view of the correlation 
that exists between periodontal infection and atherosclerosis.  
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Legends 
Figure 1.  Foam cell formation after oxLDL stimulation   
A. The ratio of cholesterol ester to total cholesterol in 30, 50 and 80 μg/mL 
oxLDL treated macrophages at 36 and 48 hr were analyzed.  At 48 hr all oxLDL 
groups showed the ratio of cholesterol ester to total cholesterol exceeing 50% (*).  
B: Numerous lipid droplets are seen aggregated in the cytoplasm in 50 μg/mL oxLDL 
treated macrophages at 48 hr as showed by Oil Red O staining.  
 
Figure 2.  Effects of P. gingivalis LPS on inflammatory cytokine transcription  
Cells were incubated with 50 µg/mL oxLDL alone or with 1 µg/mL LPS for 2 hr to 
examine the effects of LPS on oxLDL incubated macrophages. Other macrophages 
were incubated with 50 µg/mL oxLDL for 48 hr in order to induce foam cells 
formation.  These cells were then stimulated with or without 1 µg/mL LPS for a 
further 2 hr. IL-1β (A), IL-10 (B), and IL-12 (C) transcription was evaluated by 
real-time PCR. Graphs were representative of three experiments. Error bars 
represented standard deviation. * P < 0.05. 
 
Figure 3.  Protein levels in the supernatants of the macrophages and foam cells 
cultures  
Macrophages and foam cells were loaded with 50 μg/mLoxLDL and 1 μg/mL P. 
gingivalis LPS for 2, 6 and 12 hr, and levels of GM-CSF(A)  MCP-1 (B), IL-1β (C), 
IL-10 (D) and IL-12 (E) were evaluated by ELISA to prove the transcriptional data in 
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table 2 and 4 (GM-CSF and MCP-1), and figure 2 (IL-1β, IL-10 and IL-12 ). Graphs 
were representative of three independent experiments. *P < 0.05. Error bars 
represented standard deviation. 
 
Figure 4.  NF-κB pathway activation in 50 µg/mL oxLDL and 1 µg/mL LPS 
treated macrophages  
A: Immunocytochemistry was used to show nuclear translocation positive 
macrophages (arrow head), and B: the ratio of nuclear translocation positive cells 
were calculated. C-D: IκB-α level were evaluated by western blot in oxLDL alone 
or with LPS treated macrophages at 2 hr. E-F: Levels of IκB-α in 50 µg/mL oxLDL 
and 1 µg/mL LPS stimulation group during incubation. Graphs were representative 
of three experiments. Error bars represented standard deviation. *P < 0.05 
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Table 1.  Primers for Real-time PCR 
 
genes Primers for Real-time PCR Deactivation 
temperature(℃) 
Amplicon 
Size (bp) 
GAPDH 
F:5’GGGAAACTGTGGCGTGAT3’ 
R:5’GAGTGGGTGTCGCTGTTGA3’ 
59 299 
IL-1 beta 
F:5’ATGATGGCTTATTACAGTGGCA3’ 
R:5’CTGTAGTGGTGGTCGGAGATT3’ 
59 143 
IL 10 
F:5’CGCTGTCATCGATTTCTTCC3’ 
R:5’CAAACTCACTCATGGCTTTGTAGA3’ 
59 112 
IL-12 P40 
F:5’AGGGGACAACAAGGAGTATGAG3’ 
R:5’AGGGAGAAGTAGGAATGTGGAG3’ 
59 270 
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Table 2  Effects of P. gingivalis LPS and oxLDL on atherosclerotic gene expression 
in macrophages. Genes with more than 2 fold changes compared to blank control by 
oxLDL or oxLDL plus LPS stimulation were listed in light of their function. Data 
were representative of three experiments. Bold: more than 2 fold changes between 
oxLDL alone and oxLDL with LPS group. Minus fold meant down-regulated. 
 
Gene  Name  Symbol Fold changes/control Functional 
groups  oxLDL 2h oxLDL+LPS 2h 
Chemokine (C-C motif) ligand 2 CCL2 1.23±0.17 2.87±0.24  
 
Cellular 
adhesion 
molecules and 
chemokines 
Chemokine (C-C motif) ligand 5 CCL5 3.88±0.52 8.55±0.95 
CD44 molecule (Indian blood group) CD44 4.17±0.45 7.53±0.23 
Intercellular adhesion molecule 1 (CD54), 
human rhinovirus receptor 
ICAM1 3.86±0.19 2.94±0.26 
Vascular cell adhesion molecule 1 VCAM1 1.15±0.25 30.48±3.02 
Selectin E (endothelial adhesion molecule 
1) 
SELE 4.63±0.56 4.72±0.35 
Colony stimulating factor 2 
(granulocyte-macrophage) 
CSF2 18.92±3.56 225.91±14.25  
 
Growth 
factors 
Connective tissue growth factor CTGF 114.8±13.65 28.02±5.35 
Platelet-derived growth factor beta 
polypeptide  
PDGFB 2.46±0.41 1.49±0.45 
Transforming growth factor, beta 1 TGFB1 2.08±0.45 1.41±0.24 
Platelet-derived growth factor alpha 
polypeptide 
PDGFA -1.69±0.56 -10.00±11.23 
B-cell CLL/lymphoma 2 BCL2 1.27±0.35 2.18±0.12  
Apoptotic 
genes 
BCL2-related protein A1 BCL2A1 11.95±1.25 26.22±2.15 
Baculoviral IAP repeat-containing 3 BIRC3 6.14±0.45 10.86±1.25 
CASP8 and FADD-like apoptosis regulator CFLAR 3.18±1.02 3.75±0.65 
Peroxisome proliferator-activated receptor 
gamma 
PPARG -2.56±0.53 -5.26±1.23  
Nuclear 
receptors and 
transcriptional 
factors 
Nuclear receptor subfamily 1, group H, 
member 3 
NR1H3 2.25±0.53 12.54±2.15 
Nuclear factor of kappa light polypeptide 
gene enhancer in B-cells 1 (p105) 
NFKB1 1.44±0.42 2.15±0.35 
ATP-binding cassette, sub-family A 
(ABC1), member 1 
ABCA1 3.5±0.38 3.62±0.63  
Lipid 
metabolism Apolipoprotein A-I APOA1 2.17±0.45 1.06±0.35 
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Low density lipoprotein receptor (familial 
hypercholesterolemia) 
LDLR -1.96±0.14 -2.23±0.32 related genes 
Macrophage scavenger receptor 1 MSR1 -2.22±0.65 -1.89±0.61 
Interleukin 1, alpha IL1A 8.53±1.25 7.95±0.35  
Cytokines and 
other genes  
Interleukin 1 receptor, type I IL1R1 2.44±0.23 2.78±0.46 
Tumor necrosis factor (TNF superfamily, 
member 2) 
TNF 3.22±0.35 3.61±0.64 
Leukemia inhibitory factor (cholinergic 
differentiation factor) 
LIF 12.6±2.35 6.18±1.35 
Prostaglandin-endoperoxide synthase 1  PTGS1 -2.78±0.25 -6.67±1.25 
Serpin peptidase inhibitor, clade B 
(ovalbumin), member 2 
SERPINB2 -5.88±1.52 -100±8.57 
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Table 3.  Numbers of genes that were down- or up- regulated by more than 2 fold 
compared between groups.  
 
 ox2h/Ctr ox+LPS2h/Ctr ox50h/Ctr ox48h+LPS2h/Ctr ox50h/ox2h ox48h+LPS2h/ox50 
Upregulated（n） 22 26 27 31 13 11 
Downregulated （ n
） 
6 7 15 14 22 1 
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Table 4. Effects of P. gingivalis LPS and oxLDL on atherosclerotic gene 
expression in foam cells. Genes that were up- or down- regulated by more than 2 fold 
by LPS stimulation when compared to oxLDL alone were included in the table. Data 
were representative of three experiments. Minus fold meant down-regulated. 
 
 
Gene Name  Symbol Fold differences/control 
 oxLDL 50h oxLDL48h +LPS 2h 
Angiotensin I converting enzyme 
(peptidyl-dipeptidase A) 1 
ACE
 
-3.12±0.17 1.08±0.35 
B-cell CLL/lymphoma 2 BCL2
 
-1.33±0.25 2.90±0.35 
BCL2-related protein A1 BCL2A1
 
3.68±0.35 7.56±1.32 
Colony stimulating factor 2 
(granulocyte-macrophage) 
CSF2
 
151.69±15.2 323.35±12.3 
Connective tissue growth factor CTGF
 
7.70±1.20 35.03±3.32 
Early growth response 1 EGR
 
2.32±0.75 24.12±2.53 
Kinase insert domain receptor (a type III 
receptor tyrosine kinase) 
KDR
 
3.43±1.05 10.45±1.42 
Kruppel-like factor 2 (lung) KLF2
 
4.87±0.35 12.81±1.01 
Leukemia inhibitory factor (cholinergic 
differentiation factor) 
LIF
 
11.23±2.12 34.25±2.32 
Selectin E (endothelial adhesion molecule 
1) 
SELE
 
24.87±3.53 58.53±5.12 
Nuclear receptor subfamily 1, group H, 
member 3 
NR1H3
 
3.97±0.53 22.96±2.35 
Interleukin 5 (colony-stimulating factor, 
eosinophil) 
IL5 -2.38±0.48 -5.88±0.43 
 
 
 
